Distribution and anti-HBV effects of antisense oligodeoxynu-cleotides conjugated to galactosylated poly-L-lysine

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

318

HTML

1756

Figures (1-6)

112

Tables (1-2)

Sum=2279

Jun 15, 2003 (publication date) through Apr 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Jun 15, 2003; 9(6): 1251-1255
Published online Jun 15, 2003. doi: 10.3748/wjg.v9.i6.1251

Table 2 Change of serum HBsAg (the value of OD) between pretreatment and posttreatment in HBV transgenic mice

Note: Matched t test analysis showed that, compared with pretreatment,

^aP > 0.05;

^bP < 0.01.

Citation: Zheng SJ, Zhong S, Zhang JJ, Chen F, Ren H, Deng CL. Distribution and anti-HBV effects of antisense oligodeoxynu-cleotides conjugated to galactosylated poly-L-lysine. World J Gastroenterol 2003; 9(6): 1251-1255
URL: https://www.wjgnet.com/1007-9327/full/v9/i6/1251.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i6.1251